1. Home
  2. BLLN vs AX Comparison

BLLN vs AX Comparison

Compare BLLN & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$93.23

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Axos Financial Inc.

AX

Axos Financial Inc.

SELL

Current Price

$88.95

Market Cap

5.4B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
BLLN
AX
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.4B
IPO Year
2025
2004

Fundamental Metrics

Financial Performance
Metric
BLLN
AX
Price
$93.23
$88.95
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
★ $129.00
$117.71
AVG Volume (30 Days)
★ 561.3K
385.0K
Earning Date
08-05-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 103.40
14.13
EPS
0.48
★ 8.48
Revenue
★ $305,112,000.00
$81,254,000.00
Revenue This Year
$49.05
$9.81
Revenue Next Year
$26.16
$10.43
P/E Ratio
$204.98
★ $10.41
Revenue Growth
★ 99.97
23.51
52 Week Low
$61.96
$74.89
52 Week High
$150.44
$105.74

Technical Indicators

Market Signals
Indicator
BLLN
AX
Relative Strength Index (RSI) 38.68 43.56
Support Level $88.85 $84.73
Resistance Level $98.14 $99.89
Average True Range (ATR) 7.14 1.90
MACD -2.29 0.36
Stochastic Oscillator 6.44 76.82

Price Performance

Historical Comparison
BLLN
AX

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About AX Axos Financial Inc.

Axos Financial Inc is a technology-driven, diversified financial services company. Its client-centric, technology-enabled services model provides secure and scalable banking, clearing and custody, and investment advisory solutions to retail and business customers. The Bank provides consumer and commercial banking products and services through its digital online and mobile banking platforms, low-cost distribution channels and affinity partners. It offers deposit and lending products to customers nationwide including consumer and business checking, savings, etc. Its segments are Banking Business Segment and the Securities Business Segment. Majority of income comes from Banking Business Segment- It distribute its loan products through its retail, correspondent and wholesale channels.

Share on Social Networks: